Citation

S. Srinivas, Ranga V. Srinivas, G. M. Anantharamaiah, R. W. Compans, J. P. Segrest. Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins. Journal of Biological Chemistry. 1993. 268: 22895-9.

Citation

David M. Simpson, K. A. Citak, Ellen Godfrey, J. Godbold, D. E,. Wolfe. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?. Neurology. 1993. 43: 971-6.

Citation

Susan A. Fiscus, James D. Folds, Charles van der Horst. Infectious immune complexes in HIV-1-infected patients.. Viral Immunology. 1993. 6: 135-41.

Citation

Linda L. Rosendorf, Urania Dafni, David A. Amato, Barbara Lunghofer, John G. Bartlett, John M. Leedom, Diane W. Wara, John A. Armstrong, Catherine Godfrey, Eivind Sukkestad, Georg W. Counts. Performance evaluation in multicenter clinical trials: development of a model by the AIDS Clinical Trials Group. Controlled Clinical Trials. 1993. 14: 523-7.

Citation

Ross E. McKinney, J. W. Robertson. Effect of human immunodeficiency virus infection on the growth of young children. Duke pediatric AIDS clinical trials unit. Journal of Pediatrics. 1993. 123: 579-82.

Citation

F. Boucher. Phase I Evaluation of Zidovudine Adminstered to Infants Exposed at Birth to the Human Immunodeficiency Virus. Journal of Pediatrics. 1993. 122: 137-144.

Citation

Mary Jo O'Sullivan. The Pharmacokinetics and Safety of Zidovudine in the Third Trimester of Pregnancy for Women Infected With Human Immunodeficiency Virus and Their Infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group Study (Protocol 082). American Journal of Obstetrics and Gynecology. 1993. 168: 1510-1516.

Citation

E. Walter. Enhanced p24 Antigen Detection in Sera from HIV-Infected Children. Pediatric Infectious Disease Journal. 1993. 12: 94-96.

Citation

D. Richardson, Song-Heng Liou, James O. Kahn. Uric acid and didanosine compliance in AIDS clinical trials: an analysis of AIDS Clinical Trials Group protocols 116A and 116B/117.. Journal of Acquired Immune Deficiency Syndromes. 1993. 6: 1212-23.

Citation

A. Berger, Joseph Arezzo, Herbert H. Schaumburg, Gail Skowron, Thomas C. Merigan, Sam Bozzette, Douglas D. Richman, Whaijen Soo. 2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology. 1993. 43: 358-62.